Table 1 Clinical characteristics of the included studies
Study | Year | Study design | Simple size | Mean age (years) | Gender (M/F) | Fracture type | Follow-up (months) | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
La | Cro | La | Cro | La | Cro | La | Cro | La | Cro | |||
Ducic et al. [1] | 2016 | RCT | 71 | 67 | 6.50 ± 1.85 | 6.70 ± 1.6 | 43/24 | 45/26 | II/III | II/III | 11.2 ± 2.3 (8.9–13.5) | 11.2 ± 2.3 (8.9–13.5) |
Prashant et al. [2] | 2016 | RCT | 31 | 31 | 8.25 | 8.55 | 23/8 | 22/8 | III | III | 7.62 (32.64 weeks) | 7.96 (34.12 weeks) |
Shafi et al. [3] | 2013 | RCT | 100 | 100 | 5.83 ± 1.83 | 6.25 ± 2.26 | 78/22 | 80/20 | NA | NA | 3 | 3 |
Maity et al. [4] | 2012 | RCT | 80 | 80 | 6.12 ± 6.82 | 6.24 ± 1.77 | 64/16 | 48/32 | II/III | II/III | 36 | 36 |
Anwar et al. [5] | 2011 | RCT | 25 | 25 | 7.02 ± 1.25 | 7.02 ± 1.25 | NA | NA | II/III | II/III | 6 | 6 |
Gaston et al. [6] | 2010 | RCT | 47 | 57 | 5.70 | 6.20 | 22/25 | 31/26 | III | III | NA | NA |
Vaidya et al. [7] | 2009 | RCT | 29 | 31 | 5.80 | 6.20 | 21/8 | 17/14 | III | III | 6.2 | 6.6 |
Tripuraneni et al. [8] | 2009 | RCT | 20 | 20 | 4.30 | 5.50 | NA | NA | II/III | II/III | 2.17 (9.3 weeks) | 1.82 (7.8 weeks) |
Yen et al. [9] | 2008 | RCT | 28 | 24 | NA | NA | NA | NA | NA | NA | NA | NA |
Kocher et al. [10] | 2007 | RCT | 28 | 24 | 6.10 ± 1.50 | 5.70 ± 1.60 | 10/18 | 13/11 | III | III | 3 | 3 |
Foead et al. [11] | 2004 | RCT | 32 | 34 | 5.78 | 5.78 | NA | NA | II/III | II/III | NA | NA |
Karim et al. [12] | 2016 | RCT | 20 | 20 | NA | NA | NA | NA | NA | NA | NA | NA |